Here is a new PRESS release from Scanfil about how Scanfil signed a manufacturing agreement with Laerdal Medical for the Malaysian factory. 
Laerdal Medical and Scanfil have signed a manufacturing framework agreement. The products will be manufactured at Scanfil’s factory in Johor Bahru, Malaysia, which was acquired in October 2024. In January 2025, Scanfil announced an investment of 4.3 million euros in the factory to meet growing customer demand.
“We are very pleased that Laerdal Medical has chosen Scanfil and its Malaysian factory as a long-term manufacturing partner for its wide range of products. The agreement demonstrates our customers’ appreciation for our strategy to expand our manufacturing capacity in Southeast Asia,” says Christian Kesten, Scanfil’s APAC Regional Director. “Laerdal Medical trusts our ability to provide high-quality manufacturing services that meet their high standards. We are committed to supporting the Laerdal Group’s mission to improve patient outcomes and save lives with innovative healthcare solutions.”
This collaboration leverages Scanfil’s Medtech & Life Science segment’s expertise, scalable manufacturing, supply chain management, and excellent operational reliability. These will ensure the delivery of life-saving products to healthcare professionals worldwide. Deliveries will begin in mid-2025.
“We are excited about the new agreement. Scanfil has a strong reputation in supply chain management, quality, and global deliveries,” states Sjur Gausel, Strategic Sourcing Director at Laerdal Medical. “Scanfil also has long and in-depth expertise in the demanding manufacturing of medical devices, and we see this agreement as the beginning of a long-term partnership.”